SN.
NEUTRALSmith & Nephew Appoints New Non-Executive Director
The healthcare company has appointed a new independent Non-Executive Director to its Board.
Smith & Nephew
1,119.00GBX
0.54%
Market Cap
9.79B
Volume
1.72M
67% of avg
P/E Ratio
13.65
EPS (TTM)
0.82
Beta
0.62
Day Range
1,101.50p - 1,119.50p
52 Week Range
911.00p1,119.00p1,245.26p
1,119.00p
Upcoming Events
5 August 2025
Results for the first half of 2025
High Impact Event
SN.
NEUTRALSmith & Nephew Announces Director/PDMR Shareholding
The healthcare company has disclosed changes to director and PDMR shareholdings through its employee stock purchase plan.
SN.
NEUTRALSmith & Nephew Announces Director/PDMR Shareholding
The healthcare company has disclosed changes to shareholdings of its directors and other persons discharging managerial responsibilities.
SN.
NEUTRALSmith & Nephew Announces Director/PDMR Shareholding
The healthcare company has announced details of share awards vesting for certain directors and PDMRs.
SN.
NEUTRALSmith & Nephew Director Sells Shares
The healthcare company has announced a director has sold a portion of their shareholding.
SN.
NEUTRALSmith & Nephew Director Increases Shareholding
The healthcare company's non-executive director has purchased additional shares in the business.
SN.
GOODSmith+Nephew Delivers Good Q1 2025 Trading Update
The medical device maker reported a good start to 2025 with solid revenue growth across its business units, maintaining its full year guidance.
SN.
NEUTRALSmith & Nephew Plc Announces Holding Change
The healthcare company has announced a change in shareholding, with Norges Bank increasing its stake to 2.39%.
SN.
NEUTRALSmith & Nephew Announces Director Departure
The healthcare company announces the departure of an independent non-executive director.
SN.
NEUTRALSmith & Nephew Announces Timing of Q1 2025 Trading Report
The medical technology company has announced the timing of its Q1 2025 trading report.